CrushSCI.com
109.3Average days
114Median days
13Fastest days
205Longest days
1242025 publications

Paper Review Records

All Paper Review Records

11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

131 days

NSAID Tolerance Can Be Restored in NECD Even in the Absence of Complete Remission of Urticaria

Authors
Merve Hormet Igde; Pelin Korkmaz; Semra Demir; Osman Ozan Yegit; Derya Ünal; Merve Dilşad Atasever; Ayşe Feyza Aslan; Leyla Bölek; Selin Ece Güzel; Nevzat Kahveci; Mehmet Emin Sezgin; Şule Çelik Kamacı; Esra Kaya; Bircan Erden; Asli GelincikShow moreShow less
Affiliations
1. Department of Internal Medicine Division of Allergy and Clinical Immunology Istanbul University Istanbul Faculty of Medicine Istanbul TürkiyeShow moreShow less
Source PDF DOI Publisher page
113 days

Chemokines during anaphylaxis: the importance of CCL2 and CCL2-dependent chemotactic activity for basophils

Authors
Romana Vantur; Marusa Rihar; Ana Koren; Matija Rijavec; Peter Kopac; Urska Bidovec-Stojkovic; Renato Erzen; Peter KorosecShow moreShow less
Affiliations
1. University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia; 2. Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia; 3. Medical Faculty, University of Ljubljana, Ljubljana, SloveniaShow moreShow less
Source PDF DOI Publisher page
114 days

Epigenome-wide association study identifies DNA methylation markers for asthma remission in whole blood and nasal epithelium

Authors
Cancan Qi; Judith M. Vonk; Diana A. van der Plaat; Maartje A. E. Nieuwenhuis; F. Nicole Dijk; Dylan Aïssi; Valérie Siroux; H. Marike Boezen; Cheng-jian Xu; Gerard H. KoppelmanShow moreShow less
Affiliations
1. Department of Pediatric Pulmonology and Pediatric Allergy, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 2. GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 3. Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 4. University Grenoble Alpes, Inserm, CNRS, Team of environmental epidemiology applied to Reproduction and Respiratory health, IAB (Institute for Advanced Biosciences), Grenoble, France; 5. Research Group of Bioinformatics and Computational Genomics, CiiM, Centre for individualized infection medicine, A Joint Venture Between Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany; 6. Department of Gastroenterology, Hepatology and Endocrinology, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture Between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany; 7. Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the NetherlandsShow moreShow less
Source PDF DOI Publisher page
158 days

A novel ELISA method to determine human MrgX2 in chronic urticaria

Authors
Yuanyuan Ding; Tao Zhang; Rui Liu; Delu Che; Nan Wang; Langchong HeShow moreShow less
Affiliations
1. College of Pharmacy, Xi’an Jiaotong University, Xi’an, ChinaShow moreShow less
Source PDF DOI Publisher page
177 days

Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

Authors
A. Bédard; X. Basagaña; J. M. Anto; J. Garcia-Aymerich; P. Devillier; S. Arnavielhe; A. Bedbrook; G. L. Onorato; W. Czarlewski; R. Murray; R. Almeida; J. A. Fonseca; J. Correia da Sousa; E. Costa; M. Morais-Almeida; A. Todo-Bom; L. Cecchi; G. De Feo; M. Illario; E. Menditto; R. Monti; C. Stellato; M. T. Ventura; I. Annesi-Maesano; I. Bosse; J. F. Fontaine; N. Pham-Thi; M. Thibaudon; P. Schmid-Grendelmeier; F. Spertini; N. H. Chavannes; W. J. Fokkens; S. Reitsma; R. Dubakiene; R. Emuzyte; V. Kvedariene; A. Valiulis; P. Kuna; B. Samolinski; L. Klimek; R. Mösges; O. Pfaar; S. Shamai; R. E. Roller-Wirnsberger; P. V. Tomazic; D. Ryan; A. Sheikh; T. Haahtela; S. Toppila-Salmi; E. Valovirta; V. Cardona; J. Mullol; A. Valero; M. Makris; N. G. Papadopoulos; E. P. Prokopakis; F. Psarros; C. Bachert; P. W. Hellings; B. Pugin; C. Bindslev-Jensen; E. Eller; I. Kull; E. Melén; M. Wickman; G. De Vries; M. van Eerd; I. Agache; I. J. Ansotegui; S. Bosnic-Anticevich; A. A. Cruz; T. Casale; J. C. Ivancevich; D. E. Larenas-Linnemann; M. Sofiev; D. Wallace; S. Waserman; A. Yorgancioglu; D. Laune; J. BousquetShow moreShow less
Affiliations
1. ISGlobal, Barcelona, Spain; 2. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; 3. Universitat Pompeu Fabra (UPF), Barcelona, Spain; 4. IMIM (Hospital del Mar Research Institute), Barcelona, Spain; 5. UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France; 6. KYomed INNOV, Montpellier, France; 7. CHU de Montpellier, Montpellier, France; 8. Medical Consulting Czarlewski, Levallois, France; 9. Research fellow, OPC, and Director, Cambridge, UK; 10. Medscript, Paraparaumu, New Zealand; 11. Faculdade de Medicina da Universidade do Porto, Lda Porto, Portugal; 12. MEDIDA, Lda, Porto, Portugal; 13. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; 14. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal; 15. Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal; 16. UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal; 17. Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal; 18. Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal; 19. SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy; 20. Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana, University of Salerno, Salerno, Italy; 21. Division for Health Innovation, Campania Region, Federico II University Hospital Naples (R&D and DISMET), Naples, Italy; 22. CIRFF, Federico II University, Naples, Italy; 23. Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino, Mauriziano Hospital, Turin, Italy; 24. Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy; 25. Medical School Saint Antoine, Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, Sorbonne Université, Paris, France; 26. Allergist La Rochelle, La Rochelle, France; 27. Allergist, Reims, France; 28. Ecole Polytechnique Palaiseau, IRBA (Institut de Recherche bio-Médicale des Armées), Bretigny, France; 29. RNSA (Réseau National de Surveillance Aérobiologique), Brussieu, France; 30. Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 31. Service Immunologie et Allergie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 32. Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands; 33. Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands; 34. Clinic of Chest Diseases, Immunology and Allergology, Medical Faculty, Vilnius University, Vilnius, Lithuania; 35. Clinic of Children’s Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; 36. Department of Pathology, Faculty of Medicine and Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Institute of Clinical Medicine, Vilnius, Lithuania; 37. Vilnius University Institute of Clinical Medicine, Clinic of Children’s Diseases, Department of Public Health, and Institute of Health Sciences, Vilnius, Lithuania; 38. European Academy of Paediatrics, EAP/UEMS-SP), Brussels, Belgium; 39. Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland; 40. Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland; 41. Center for Rhinology and Allergology, Wiesbaden, Germany; 42. Medical Faculty, CRI-Clinical Research International-Ltd, Institute of Medical Statistics, and Computational Biology, University of Cologne, Hamburg, Germany; 43. Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany; 44. Department of Internal Medicine, Medical University of Graz, Graz, Austria; 45. Department of ENT, Medical University of Graz, Graz, Austria; 46. Honorary Clinical Research Fellow, Allergy and Respiratory Research Group, The University of Edinburgh, Edinburgh, UK; 47. The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK; 48. Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland; 49. Department of Lung Diseases and Clinical Immunology, University of Turku, Terveystalo Allergy Clinic, Turku, Finland; 50. Allergy Section, Department of Internal Medicine, Hospital Vall d’Hebron, ARADyAL Research Network, Barcelona, Spain; 51. Rhinology Unit, & Smell Clinic, ENT Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain; 52. Pneumology and Allergy Department CIBERES and Clinical, & Experimental Respiratory Immunoallergy, IDIBAPS, University of Barcelona, Barcelona, Spain; 53. Allergy Unit “D Kalogeromitros”, 2nd Dpt of Dermatology and Venereology, National & Kapodistrian University of Athens, “Attikon” University Hospital, Athens, Greece; 54. Division of Infection, & Respiratory Medicine, Royal Manchester Children’s Hospital Immunity, University of Manchester, Manchester, UK; 55. Allergy Department, 2nd Pediatric Clinic, Athens General Children’s Hospital “P&A Kyriakou,” University of Athens, Athens, Greece; 56. Department of Otorhinolaryngology, University of Crete School of Medicine, Heraklion, Greece; 57. Allergy Department, Athens Naval Hospital, Athens, Greece; 58. Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgium; 59. Sun Yat-sen University, International Airway Research Center, Guangzou, China; 60. Division of ENT Diseases, CLINTEC, Karolinska Institutet, Stockholm, Sweden; 61. Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden; 62. Academic Medical Center, Univ of Amsterdam, Dept of Otorhinolaryngology, Univ Hospitals Leuven, Leuven, The Netherlands; 63. European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium; 64. Odense University Hospital, Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark; 65. Thermofisher Scientific, Uppsala, Sweden; 66. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sach´s Children and Youth Hospital, Södersjukhuset, Sweden; 67. Sachs’ Children and Youth Hospital, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 68. Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden; 69. Peercode BV, Geldermalsen, The Netherlands; 70. Transylvania University Brasov, Brasov, Romania; 71. Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain; 72. Woolcock Institute of Medical Research, University of Sydney, Woolcock Emphysema Centre, Sydney Local Health District, Glebe, Australia; 73. Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil; 74. WHO GARD Planning Group, Salvador, Brazil; 75. Division of Allergy/Immunology, University of South Florida, Tampa, USA; 76. Clinica Santa Isabel, Servicio de Alergia e Immunologia, Buenos Aires, Argentina; 77. Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico; 78. Finnish Meteorological Institute (FMI), Helsinki, Finland; 79. Nova Southeastern University, Fort Lauderdale, USA; 80. Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, Canada; 81. Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey; 82. University Hospital, Montpellier, France; 83. INSERM U 1168, VIMA : Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France; 84. Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny Le Bretonneux, France; 85. Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; 86. Department of Dermatology and Allergy, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, GermanyShow moreShow less
Source PDF DOI Publisher page
130 days

A pragmatic randomized controlled trial to improve inhaler technique using mHealth

Authors
Anna Vanoverschelde; Paulien van der Wel; Barbara Putman; Lies LahousseShow moreShow less
Affiliations
1. Department of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ghent, Belgium; 2. Department of Medicine and Department of Environmental Medicine, New York University School of Medicine, New York, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Clinical and Translational Allergy take to review a manuscript?

As of 2026-11-19, CrushSCI has 11 complete review records for Clinical and Translational Allergy. The fastest paper went from submission to acceptance in 13 days (Highlights and recent developments in allergic diseases in EAACI journals (2019), received 2020-11-13, accepted 2020-11-26); the slowest took 205 days. The average is 109.3 days and the median is 114 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.